|
Rhabdomyolysis is a rare condition where serious muscle damage results in release of muscle cell contents into the bloodstream. Rhabdomyolysis may result in kidney damage and other organ damage which can be fatal. All statins have been associated to the risk of rhabdomyolysis but Baycol was found to have a much higher occurrence. Rhabdomyolysis occurs when a large number of skeletal muscle tissue die (necrosis). This muscle damage results in the release of the contents of the muscle cells, including muscle protein (myogloblin) into the bloodstream. The major complication of rhabdomyolysis is acute kidney failure. The most common symptom of rhabdomyolysis is muscle ache and or tenderness in the back muscles, legs and arms. Other symptoms include fever, nausea, vomiting and a general feeling of weakness. Severe rhabdomyolysis symptoms may include:
In addition to these rhabdomyolysis symptoms, rhabdomyolysis may be indicated if a urinalysis (test of the urine) and blood analysis reveal increased levels of myoglobin in the system. There are other components of urinalysis and blood testing that indicate rhabdomyolysis. These indicators can be explained by your doctor. The greatest risk of injury or death is from Baycol users who took it in combination with Lopid. Lopid is the trade name for Gemfibrozil, a fibrate. The two drugs alter blood fats in different ways. Other high risk groups include older patients and patients who were taking high doses of Baycol (.8 milligram dose). If you feel you have been harmed by use of Baycol, click
here to have an attorney review your case for free, with no
obligation. Or, call us toll free at 877.786.1LAW (1529). |